Within the past years, up to 78% of FDA-regulated clinical trials for the top pharmaceutical & medical device companies are conducted outside the U.S.
In the past 15 months, since the World Health Organization declared Covid-19 as a pandemic, healthcare systems around the globe have been under immense clinical trials R&D and regulatory pressure.
In what areas does America’s health system excel, and how it would evolve in the next 5 years? do we need more or less regulations, greater investments in certain areas or enhance competition?
The United States has what is arguably the most complex healthcare system in the world. As a result, changes within the industry are slow. To understand what may come, it helps to have a deeper understanding of healthcare’s complexity.
What challenges has Covid-19 Global Pandemic created or exacerbated – within the Clinical Trials Development Life Sciences during 2020 & 2021
The challenges from the impact of COVID-19 in the Clinical Research has pivot into decentralized (virtual) Clinical Research trials.
What new opportunities has the Covid-19 global pandemic crisis has uncovered at ESTERN Medical CRO Life Sciences and our positive progress that has catalyzed within our company in the US North America & Latin America
During the past year 2020 and present 2021 our company has engaged in diverse solutions to catalyzed or accelerate processes in diverse angles in this global pandemic, internally and externally, to our Life Sciences clients.